Wilson & Boucher Capital Management’s Eli Lilly LLY Stock Holding History

Wilson & Boucher Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$655K	Sell	546 -2	-0.4%	-$2.04K	0.38%	63
2026 Q1	$504K	Buy	548 +6	+1%	+$6.08K	0.33%	72
2025 Q4	$583K	Sell	542 -50	-8%	-$47.8K	0.38%	64
2025 Q3	$452K	Hold	592	–	–	0.3%	78
2025 Q2	$462K	Sell	592 -7	-1%	-$5.44K	0.32%	78
2025 Q1	$495K	Sell	599 -40	-6%	-$33.3K	0.37%	74
2024 Q4	$493K	Sell	639 -101	-14%	-$83.6K	0.35%	75
2024 Q3	$656K	Buy	740 +101	+16%	+$90.8K	0.45%	59
2024 Q2	$578K	Buy	639 +262	+69%	+$210K	0.44%	61
2024 Q1	$294K	Buy	+377	New	+$268K	0.23%	91

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wilson & Boucher Capital Management's LLY Position: Q2 2026 in Review

Wilson & Boucher Capital Management reduced its Eli Lilly (LLY) stake by 0.36% in Q2 2026, selling an estimated $2.04K and leaving 546 shares worth $655K. The position accounts for 0.38% of the portfolio, ranked #63.

Wilson & Boucher Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $656K in Q3 2024. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Wilson & Boucher Capital Management held 546 shares of Eli Lilly worth $655K as of Q2 2026.
Wilson & Boucher Capital Management sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
Eli Lilly made up 0.38% of Wilson & Boucher Capital Management's portfolio in Q2 2026, its #63 holding.
Wilson & Boucher Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
Wilson & Boucher Capital Management's Eli Lilly position peaked at $656K in Q3 2024.
4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wilson & Boucher Capital Management's 13F filing for Q2 2026, filed 19 Aug 2026.